Vladimir Kolesnichenko PhD

Vladimir Kolesnichenko PhD

Professor
  • Synthesis and     characterization of ultrasmall magnetic nanoparticles for biomedical     applications.
  • we are developing novel MRI imaging agents which be     selectively recognized by cancerous cells.  Their size and     amphiphilic properties will be optimized to avoid phagocytic and     early renal clearance, which will make them an effective tool for early     detection of cancer.  
  • National Taras Shevchenko University, Kyiv, Ukraine     (BS, MS); Institute of General and Inorganic Chemistry, Kyiv,     Ukraine (PhD); The University of Iowa (Postdoc)
  • ORCID: https://orcid.org/0000-0001-5497-7085
  • NCBI: https://www.ncbi.nlm.nih.gov/sites/myncbi/1hEVrJkxduZ5J/bibliography/48720938/public/?page=1
  • Selected publications: (a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces.  Rajesh Komati, Carl     Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir     Kolesnichenko, Chemistry-A European Journal, 2018, 24, 14824-14829.      (b) A Versatile Method of Ambient-Temperature Solvent Removal. Igor     Kolesnichenko, Galina Goloverda and Vladimir Kolesnichenko, Organic     Process Research & Development, 2020, 24, 25-31.
  • Keywords: superparamagnetic nanoparticles, MRI contrast agents

LCRC Faculty

Ambuga Badari, MD
Translational Oncology
Ochsner Health
Van Barnes, PhD
Cancer Biology
Tulane University School of Medicine
Collette Baudoin, PhD
Population Sciences
LSU Health - New Orleans
Victoria P. Belancio PhD
Genes X Environment
Tulane University School of Medicine
Jorge A. Belgodere ,PhD
Population Sciences
Tulane University School of Medicine
Earl "Nupsius" Benjamin-Robinson DrHSc CPH
Population Sciences
Louisiana Cancer Research Center
Hector Biliran PhD
Cancer Biology
Xavier University
Tom Bishop PhD
Genes X Environment
Louisiana Tech University
David Blask MD PhD
Cancer Biology
Tulane University School of Medicine